Using a partially observable Markov chain model to assess colonoscopy screening strategies - A cohort study

Colorectal cancer (CRC) is notoriously hard to combat for its high incidence and mortality rates. However, with improved screening technology and better understanding of disease pathways, CRC is more likely to be detected at early stage and thus more likely to be cured. Among the available screening methods, colonoscopy is most commonly used in the U.S. because of its capability of visualizing the entire colon and removing the polyps it detected. The current national guideline for colonoscopy screening recommends an observation-based screening strategy. Nevertheless, there is scant research studying the cost-effectiveness of the recommended observation-based strategy and its variants. In this paper, we describe a partially observable Markov chain (POMC) model which allows us to assess the cost-effectiveness of both fixed-interval and observation-based colonoscopy screening strategies. In our model, we consider detailed adenomatous polyp states and estimate state transition probabilities based on longitudinal clinical data from a specific population cohort. We conduct a comprehensive numerical study which investigates several key factors in screening strategy design, including screening frequency, initial screening age, screening end age, and screening compliance rate. We also conduct sensitivity analyses on the cost and quality of life parameters. Our numerical result demonstrates the usability of our model in assessing colonoscopy screening strategies with consideration of partial observation of true health states. This research facilitates future design of better colonoscopy screening strategies.

[1]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[2]  Hermann Brenner,et al.  Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.

[3]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[4]  Lisa M. Maillart,et al.  Assessing Dynamic Breast Cancer Screening Policies , 2008, Oper. Res..

[5]  Brian T. Denton,et al.  Optimization of Prostate Biopsy Referral Decisions , 2012, Manuf. Serv. Oper. Manag..

[6]  B. Manns,et al.  Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation , 2010, PLoS medicine.

[7]  Timothy D. Imler,et al.  The effect of colonoscopy preparation quality on adenoma detection rates. , 2012, Gastrointestinal endoscopy.

[8]  Robert W. Klein,et al.  Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .

[9]  Michael Pignone,et al.  Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults , 2005 .

[10]  D. Rex,et al.  Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009 .

[11]  I. Sobhani,et al.  Cost-Effectiveness of Mass Screening for Colorectal Cancer: Choice of Fecal Occult Blood Test and Screening Strategy , 2011, Diseases of the colon and rectum.

[12]  E. Arias,et al.  United States life tables, 2006. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[13]  J. Habbema,et al.  Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. , 2011, Gastroenterology.

[14]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[15]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[16]  A. N. Lee,et al.  U. S. NATIONAL CENTER FOR HEALTH STATISTICS , 1968 .

[17]  P. Grenier,et al.  Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests. , 2012, European journal of radiology.

[18]  A. Verbeek,et al.  Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost‐effectiveness analysis , 2011, International journal of cancer.

[19]  Joel Lexchin,et al.  Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review , 2010, PLoS medicine.

[20]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[21]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[22]  Lijun Wang,et al.  Development of a simulation model of colorectal cancer , 2007, TOMC.

[23]  Angela Mariotto,et al.  Cancer Intervention and Surveillance Modeling Network (CISNET) , 2001, Journal of Investigative Medicine.

[24]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..

[25]  Carolyn M Rutter,et al.  An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and Application , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[26]  A. Fendrick,et al.  Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.

[27]  Turgay Ayer,et al.  OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions , 2012, Oper. Res..

[28]  Michael E. Chernew,et al.  Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  Michael Devetsikiotis,et al.  An adaptive approach to accelerated evaluation of highly available services , 2007, TOMC.

[30]  J D Habbema,et al.  Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.

[31]  S. Peacock,et al.  Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada. , 2012, European journal of cancer.

[32]  Brian T. Denton,et al.  Optimization of PSA Screening Policies , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  Daniel Frederick Cubbage Simulation of Colorectal Cancer: The natural history of disease , 2004 .

[34]  Barry L. Nelson,et al.  Numerical Methods for Fitting and Simulating Autoregressive-to-Anything Processes , 1998, INFORMS J. Comput..

[35]  A. Fendrick,et al.  Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  Stephen D. Roberts,et al.  Probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer , 2009, TOMC.

[37]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[38]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[39]  M. Mcgrath Cost Effectiveness in Health and Medicine. , 1998 .

[40]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[41]  Eric J Feuer,et al.  Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[42]  Janneke Wilschut,et al.  At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach , 2009, International journal of cancer.

[43]  Douglas K Rex,et al.  Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.

[44]  James J. Nutaro,et al.  On constructing optimistic simulation algorithms for the discrete event system specification , 2008, TOMC.

[45]  J. GarcíaSánchez [Colonoscopic polypectomy and long-term prevention of colorectal cancer deaths]. , 2012 .

[46]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.